Nasdaq Moves to Delist Moolec, Trading Suspended November 3
MLEC is trading near its 52-week low of $0.8 (5.0% above the low) on elevated volume (3.0× avg).
Summary
Nasdaq issued a Staff Delisting Determination on October 27, 2026, and will suspend trading in Moolec's ordinary shares at the open on November 3, 2026, before filing a Form 25-NSE with the SEC to complete the delisting. The move follows the October 20 shareholder vote approving voluntary winding-up, which passed with 98.4% of votes cast, and the appointment of Joint Voluntary Liquidators. This is the expected consequence of the liquidation approved two weeks ago, not a new dispute with the exchange. The stock is effectively at the end of its public-market life: the delisting removes Nasdaq trading, and any residual value now depends on the liquidators' distribution process. The 6-K filed today also disclosed the CEO and CFO resigned effective immediately, with control transferred to the Joint Voluntary Liquidators.
At the time of this announcement, MLEC was trading at $0.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $617.2K. The 52-week trading range was $0.80 to $23.22. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: ACCESS Newswire.